Skip to main content
OpenTrials
Completed

NCT Number: NCT01263067

Lifespan Integration for Posttraumatic Stress Disorder From an Auto Accident

The purpose of this study is to evaluate if lifespan integration (LI) therapy reduces posttraumatic stress symptoms following a motor vehicle accident (MVA) trauma

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Argosy University Seattle

Seattle, Washington, 98103, United States

About this study

Studies estimate a substantial proportion of MVA survivors, ranging from 9.4% to 59.9%, will develop PTSD following an accident (Blanchard & Hickling, 2004). Based on conservative estimates, past research, indicates that MVA-related PTSD may affect 2.5 to 7 million persons in the United States (Blanchard & Hickling). Furthermore, two seminal epidemiological studies (Kessler et al., 1995; Norris, 1992) that focused on causes of adult PTSD identified MVAs as the most frequent trauma resulting in PTSD. For these reasons, MVA-resultant PTSD represents a significant public health problem that needs not only to be thoroughly understood, but addressed with successful mental health treatment options (Beck & Coffey, 2007; Blanchard & Hickling, 1997, 2004; Bryant et al., 1998; Taylor et al., 1999; Taylor et al., 2001). Although there is empirical literature on the treatment of PTSD following an MVA, additional efficacious and rigorously conducted studies with statistical underpinnings are required to determine the results that can be expected from alternative models of care (Beck & Coffey; Blanchard & Hickling, 1997, 2004).

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Involved in or witnessed a car accident at least 6 months ago.
  • PTSD or distress or impairment in important areas of functioning following the car accident

Exclusion criteria

  • moderate or severe head injury
  • current mental health treatment for the MVA-related problem
  • severe chronic pre-injury mental health problems

Treatment and study plan

Lifespan Integration Therapy

Behavioral

LI treatment guides the client to imaginally visit past memories, and then leads her or him forward through time to the present using a concept referred to as the time line. Beginning with the individual's memories from the traumatic experience, the time line first follows memories from the days and weeks after the trauma, then season by season to the present, and is reviewed in ongoing sessions as increasing details of the traumatic event are uncovered.

Lifespan Integration- Control

Behavioral

Participants selected for the control group will be treated 4 weeks following initial contact. Treatment is the same as for the Experimental Group.

Primary outcomes

  1. Clinicians Administered PTSD Scale

    Time frame: following the final treatment session (average of 6 weeks from treatment start date)

    Participants will be assessed with the CAPS following the final treatment session (up to 5 treatment sessions).

Secondary outcomes

  1. Personality Assessment Inventory

    Time frame: following the final treatment session (average of 6 weeks from treatment start date)

Sponsors and collaborators

Lead sponsor

Argosy University

Other

Registry information

Official study title

Lifespan Integration Therapy for Posttraumatic Stress Disorder of Adults Involved in an Auto Accident

Important dates

Study start
2010
Primary completion
2011
Study completion
2012
First posted
Dec 20, 2010
Registry last updated
Jan 14, 2015

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.